Liver Disease Treatments: The Global Market

Published - Jun 2009| Analyst - Shalini Shahani Dewan| Code - PHM057A
Market Research Report Single User License: $2750 Member Price: FREE

Report Highlights

  • The global market for liver disease treatments amounted to nearly $8.4 billion in 2007 and is expected to increase to $9.8 billion in 2014, for a compound annual growth rate (CAGR) of 3.0%
  • The treatment for hepatitis is the largest segment of the market, amounting to about $4.6 billion in the last three years, and is expected to reach $4.8 billion in 2014.
  • Sales of targeted therapies were comparatively less in 2008, but this market has the potential to grow faster mainly because of the increased incidence of hepatitis C in developing countries.



BCC's goal in conducting this study is to provide an overview of the current and potential aspects of the global market for liver diseases treatments. The report determines the market size and market leaders, provides a market overview, and examines factors affecting the markets for drugs used to treat liver diseases. The markets have been defined by disease type and by drug type. 

The overview of types of liver diseases, their symptoms and their treatments is examined along with sales figures over the five-year period from 2009 to 2014. The report also gives the demand and use criteria of the drugs used to treat liver diseases, as well as an overview of drug-induced liver diseases. Companies manufacturing and selling the drug products in this category are profiled, and factors affecting markets for these products and how the markets are likely to change are analyzed. Revenues have been broken down by the type of diseases and by different regions. 
Our key objective is to present a comprehensive analysis of the current market and the future direction of the drugs used to treat liver diseases.
A large number of studies are currently ongoing regarding hepatitis and other liver diseases, which influenced BCC’s desire to study this market.
This study looks at almost all of the types of products used to treat liver diseases, The research and development of new products, and the changes in market behavior that justify focusing on this segment. Finally, this study discusses the usage of these products.
The study contributes to understanding market growth and decline in the market for liver disease treatments, from the point of view of the manufacturer and user.  This study will be of interest largely to the chemical, pharmaceutical and biopharmaceutical industries, as well as clinics and hospitals.  
The scope of this study encompasses the market for liver disease treatments. BCC analyzes each market and its leaders, the different types of liver diseases, the different types of drug products to treat liver diseases, the regulatory environment, the regional market for liver diseases and the drug products used to treat them, and market projections and market share. Technological issues include latest trends and new developments.
A combination of primary and secondary research methods were used in this study. A comprehensive search of literature was conducted.  The literature included technical newsletters and journals as well as many other sources. The data were collected through interviews and correspondence with various pharmaceutical/ biotechnical experts. Projections were based on estimates such as the current number of end users, potential end users, likely unit prices, rates of consumption, and market trends.
BCC surveyed many companies to obtain data for this study. Included were manufacturers and the end users of the drugs used to treat liver diseases. We gathered industry data, spoke with officials from this industry, and consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were done. In addition, we compiled data from current financial and trade information and government sources.
Shalini Shahani Dewan holds a Masters Degree in pharmaceutical chemistry.  Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shahani was awarded a gold medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are: Reagents of Chromatography; Spectroscopy, an Enduring Market; Advanced Drug Delivery Systems; Orthopedic Drugs, Implants and Devices; Imaging Reagents; Contract Manufacturing, Research and Packaging; The Dynamic Media, Sera and Reagent Market in Biotechnology; Opportunities in Chiral Technology; Behavioral and Emotional Disorders in Children and Adolescents; Pharmaceutical Regulatory Industry,and many more.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Note: Reports are discounted or included with certain Memberships. See Membership Options.

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report